These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 20870279)
1. Nonfatal self-poisoning with LMW heparin and the use of antidote. Bjornaas MA; Jacobsen EM; Jacobsen D Thromb Res; 2010 Nov; 126(5):e403-5. PubMed ID: 20870279 [No Abstract] [Full Text] [Related]
2. Intraoperative heparin anticoagulation and its reversal. Wakefield TW; Stanley JC Semin Vasc Surg; 1996 Dec; 9(4):296-302. PubMed ID: 8958606 [No Abstract] [Full Text] [Related]
4. Reversal of anticoagulant activity of heparin and low molecular weight heparins by poly-l-lysine: A comparative 'in vitro' study versus protamine sulfate. Muralidharan-Chari V; Kim J; Mousa SA Thromb Res; 2017 Jul; 155():128-130. PubMed ID: 28538195 [No Abstract] [Full Text] [Related]
5. [Heparin in surgery and artificial circulation: pro and contra. Is there an alternative?]. Roĭtman EV; Dement'eva II; Meshcheriakov AV Anesteziol Reanimatol; 1997; (6):65-9. PubMed ID: 9511253 [No Abstract] [Full Text] [Related]
6. Razor blades, heparin and protamine--a potent mix. Quirke M; O'Donnell JJ Ir Med J; 2011 Apr; 104(4):126. PubMed ID: 21675101 [No Abstract] [Full Text] [Related]
7. Neutralization of enoxaparine-induced bleeding by protamine sulfate. Van Ryn-McKenna J; Cai L; Ofosu FA; Hirsh J; Buchanan MR Thromb Haemost; 1990 Apr; 63(2):271-4. PubMed ID: 2163553 [TBL] [Abstract][Full Text] [Related]
8. Must heparin be neutralized following open-heart operations? Castaneda AR J Thorac Cardiovasc Surg; 1966 Nov; 52(5):716-24. PubMed ID: 5955183 [No Abstract] [Full Text] [Related]
9. [Protamin-sulfate in cardiac surgery: between Scilla and Haribda]. Charnaia MA; Morozova IuA; Gladysheva VG Khirurgiia (Mosk); 2006; (12):45-9. PubMed ID: 17419491 [No Abstract] [Full Text] [Related]
10. Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention. Patel AA; White CM; Coleman CI Conn Med; 2007 Feb; 71(2):93-5. PubMed ID: 17393902 [No Abstract] [Full Text] [Related]
11. Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass. Gruenwald CE; Manlhiot C; Chan AK; Crawford-Lean L; Foreman C; Holtby HM; Van Arsdell GS; Richards R; Moriarty H; McCrindle BW J Am Coll Cardiol; 2010 Nov; 56(22):1794-802. PubMed ID: 21087706 [TBL] [Abstract][Full Text] [Related]
12. Impact of heparin neutralization by protamine on restenosis after coronary stent implantation. Kaneda H; Suzuki J; Hosokawa G; Tanaka S; Hiroe Y; Saito S Int J Cardiol; 2005 Oct; 105(1):111-2. PubMed ID: 16207558 [No Abstract] [Full Text] [Related]
13. Anticoagulation and reversal paradigms: is too much of a good thing bad? Levy JH; Tanaka KA Anesth Analg; 2009 Mar; 108(3):692-4. PubMed ID: 19224768 [No Abstract] [Full Text] [Related]
15. Incomplete reversal of enoxaparin toxicity by protamine: implications of renal insufficiency, obesity, and low molecular weight heparin sulfate content. Chawla LS; Moore G; Seneff MG Obes Surg; 2004 May; 14(5):695-8. PubMed ID: 15186641 [TBL] [Abstract][Full Text] [Related]
16. Protamine neutralization of the release of tissue factor pathway inhibitor activity by heparins. Harenberg J; Siegele M; Dempfle CE; Stehle G; Heene DL Thromb Haemost; 1993 Dec; 70(6):942-5. PubMed ID: 8165616 [TBL] [Abstract][Full Text] [Related]
17. Coronary perforation during unprotected left main angioplasty. Management with conservative approach: a case report. Villa M; de la Llera LD; Morán JE; Pérez-Cortacero JA; Fournier JA Int J Cardiol; 2004 Oct; 97(1):145-6. PubMed ID: 15336825 [No Abstract] [Full Text] [Related]